Fresolimumab and Radiotherapy in Metastatic Breast Cancer

NCT01401062 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Fresolimumab
RADIATION: Radiation Therapy

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]